世界卫生组织儿童疑似结核病治疗决策算法的诊断准确性:一项个体参与者数据荟萃分析
该研究利用四个儿童队列的个体参与者数据,对世界卫生组织(WHO)2022年推荐的两套治疗决策算法(TDA A含胸片、TDA B不含胸片)进行回顾性外部评估。在1886名疑似肺结核儿童中,TDA A和TDA B的敏感性分别为84.3%和90.6%,特异性分别为50.6%和30.8%。结论认为两套算法敏感性高但特异性欠佳,需前瞻性研究评估包含分诊步骤的完整算法。
要点
- 在1886名疑似肺结核儿童中,TDA A敏感性84.3%、特异性50.6%,TDA B敏感性90.6%、特异性30.8%。
- 高危组儿童(含HIV感染、严重急性营养不良、<2岁)使用TDA A的敏感性低于低危组,但特异性高于低危组。
- 作者认为需开展前瞻性研究评估包含分诊步骤的完整治疗决策算法。
核心结论
- 在大型个体参与者数据集中对WHO治疗决策算法进行回顾性外部评估显示,两套算法敏感性高但特异性欠佳,与生成这些算法的荟萃分析结果一致。
- 作者认为需要开展前瞻性研究评估包含分诊步骤的完整治疗决策算法,并将新型诊断工具整合入算法以提高准确性尤其是特异性。
研究设计与样本
- 研究为对WHO治疗决策算法的回顾性外部评估,使用个体参与者数据集(IPD),该数据集包含四个儿童队列,限于10岁以下疑似肺结核儿童,并纳入高危组儿童(HIV感染儿童、严重急性营养不良儿童及2岁以下儿童)。
- 共纳入1886名儿童(RaPaed-TB队列n=740,Umoya队列n=474,TB-Speed HIV队列n=204,TB-Speed Decentralisation队列n=468),中位年龄2.9岁(四分位距1.3至5.5岁),741名(39.3%)不足2岁,382名(20.3%)为HIV感染儿童,284名(15.1%)有严重急性营养不良。
- 所有儿童均回顾性评估TDA A(含胸部X线的算法)和TDA B(不含胸部X线的算法),评估时排除分诊步骤,以复合参考标准(确诊和未确诊结核 versus 不太可能结核)确定诊断准确性,报告敏感性和特异性。
主要发现
- 281名(14.9%)为确诊结核,672名(35.6%)分类为未确诊结核(临床诊断、微生物学检查阴性),933名(49.5%)分类为不太可能结核。
- TDA A敏感性为84.3%(95%CI:74.8至90.6),特异性为50.6%(95%CI:30.4至70.7);TDA B敏感性为90.6%(95%CI:83.8至94.7),特异性为30.8%(95%CI:21.5至42.0)。
- 对于TDA A,高危组儿童估计敏感性为83.0%(95%CI:79.4%至86.1%),低于低危组的88.0%(95%CI:84.8%至90.6%);高危组特异性为50.0%(95%CI:44.9%至55.1%),高于低危组的36.6%(95%CI:32.7%至40.7%)。
- TDA B的趋势与TDA A相似。
关键数值与推荐
- TDA A(含胸部X线)敏感性84.3%(95%CI:74.8至90.6),特异性50.6%(95%CI:30.4至70.7)。
- TDA B(不含胸部X线)敏感性90.6%(95%CI:83.8至94.7),特异性30.8%(95%CI:21.5至42.0)。
- TDA A在高危组敏感性83.0%(95%CI:79.4%至86.1%),特异性50.0%(95%CI:44.9%至55.1%);低危组敏感性88.0%(95%CI:84.8%至90.6%),特异性36.6%(95%CI:32.7%至40.7%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 大多数儿童结核病诊断研究(包括纳入IPD的两项研究)在医疗水平较高的二级或三级医院进行,因此目标人群可能与IPD有所不同,可能限制结果的普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: In 2023, almost 200,000 children under 15 years died from tuberculosis, most without appropriate treatment. Treatment decision algorithms (TDAs), developed to facilitate rapid anti-tuberculosis treatment initiation in children, were recommended by the World Health Organization (WHO) in 2022, conditional on validation in different cohorts and settings. We performed a retrospective external evaluation of WHO TDAs using an individual participant dataset (IPD). METHODS AND FINDINGS: The IPD comprised four paediatric cohorts, restricted to children with presumptive pulmonary TB < 10 years, and including children in high-risk groups (children living with HIV "CLHIV", children with severe acute malnutrition "SAM", and children <2 years). All children in the IPD were retrospectively evaluated using both TDA A (an algorithm including chest X-ray) and TDA B (without chest X-ray), excluding the triage step. The diagnostic accuracy against a composite reference standard (confirmed and unconfirmed tuberculosis versus unlikely tuberculosis) was determined and reported as sensitivities and specificities. Of 1,886 children included (RaPaed-TB: n = 740, Umoya: n = 474, TB-Speed HIV: n = 204, TB-Speed Decentralisation: n = 468), the median age was 2.9 years (interquartile range [IQR]:1.3,5.5), 741 (39.3%) were <2 years, 382 (20.3%) were CLHIV, and 284 (15.1%) had SAM. 281 (14.9%) had confirmed tuberculosis, 672 (35.6%) were classified as unconfirmed tuberculosis (clinically diagnosed, microbiological investigations negative), and 933 (49.5%) as unlikely tuberculosis. For TDAs A and B, algorithm sensitivity was 84.3% (95% CI: 74.8, 90.6) and 90.6% (95% CI: 83.8, 94.7), respectively, with a specificity of 50.6% (95% CI: 30.4, 70.7) and 30.8% (95% CI: 21.5, 42.0), respectively. For TDA A, estimated sensitivity in children in high-risk groups was lower than those with low-risk (83.0%, 95% CI: 79.4%, 86.1%; versus 88.0%, 95% CI: 84.8%, 90.6%), while having a gain in specificity (50.0%, 95% CI: 44.9%, 55.1%; versus 36.6%, 95% CI: 32.7%, 40.7%). Trends were similar for TDA B. As for limitations, most diagnostic tuberculosis studies in children, including two of those included in the IPD, are performed at secondary or tertiary hospitals with higher levels of healthcare and thus the target population might differ somewhat from the IPD, potentially limiting the generalisability of our results. CONCLUSIONS: This retrospective external evaluation of WHO TDAs in a large IPD shows high sensitivity but sub-optimal specificity for both TDAs, in line with the meta-analyses that generated the algorithms. Prospective studies that evaluate the entire TDA, including triage step are needed. Additionally, the integration of novel diagnostic tools within the TDAs should aim to enhance the accuracy, especially the specificity.
引用
- Olbrich L, Larsson L, Dunbar R, et al. Diagnostic accuracy of the WHO tuberculosis treatment decision algorithms for children with presumptive tuberculosis: An individual participant data meta-analysis. PLoS Med. 2025. PMID: 41252347. doi:10.1371/journal.pmed.1004610
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。